Pricing Log in Create free account

Black Diamond Therapeutics, Inc. (BDTX) vs Polaryx Therapeutics, Inc. (PLYX)

Black Diamond Therapeutics, Inc. and Polaryx Therapeutics, Inc. are both Biotechnology companies. Black Diamond Therapeutics, Inc. and Polaryx Therapeutics, Inc. are of similar size ($97.2M and $92.5M). Across the 8 metrics below, Black Diamond Therapeutics, Inc. leads on 4 and Polaryx Therapeutics, Inc. on 4.

Valuation

Metric BDTX PLYX Biotechnology median
P/E n/m n/m 11.58
P/S n/m n/m 9.61
P/B 0.96 8.61 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 0.35 n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (46.58%) (11.10%) (32.28%)
Free cash flow yield (35.52%) (8.75%) (22.27%)

Profitability

Metric BDTX PLYX Biotechnology median
Gross margin 0.00% — 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (37.21%) 0.00% (50.30%)
Return on assets (29.21%) (169.05%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDTX PLYX Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) 130.71% 77.72% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BDTX PLYX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.28 13.53 4.74
Net debt to EBITDA (10.01) 0.66 1.01

Dividend

Metric BDTX PLYX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric BDTX PLYX Biotechnology median
Market cap 92.50m 97.20m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack